Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018”.
Miloš D. Miljković, Vinay Prasad, Patrick DeMartino